Abstract
Introduction
External fractionated radiotherapy of cancer increases the risk of cardio- and cerebrovascular events, but less attention has been paid to the potential side effects on the arteries following internal radiotherapy with radioactive iodine (RAI), i.e. 131-iodine. About 279 per million citizens in the western countries are treated each year with RAI for benign thyroid disorders (about 140,000 a year in the EU), stressing that it is of clinical importance to be aware of even rare radiation-induced side effects. In order to induce or accelerate atherosclerosis, the dose to the carotid arteries has to exceed 2 Gy which is the known lower limit of ionizing radiation to affect the endothelial cells and thereby to induce atherosclerosis.
Objective
To estimate the radiation dose to the carotid arteries following RAI therapy of benign thyroid disorders.
Methods
Assuming that the lobes of the thyroid gland are ellipsoid, that the carotid artery runs through a part of the lobes, that there is a homogeneous distribution of RAI in the lobes, and that the 24 h RAI uptake in the thyroid is 35 % of the 131I orally administrated, we used integrated modules for bioassay analysis and Monte Carlo simulations to calculate the dose in Gy/GBq of administrated RAI.
Results
The average radiation dose along the arteries is 4–55 Gy/GBq of the 131I orally administrated with a maximum dose of approximately 25–85 Gy/GBq. The maximum absorbed dose rate to the artery is 4.2 Gy/day per GBq 131I orally administrated.
Conclusion
The calculated radiation dose to the carotid arteries after RAI therapy of benign thyroid disorder clearly exceeds the 2 Gy known to affect the endothelial cells and properly induce atherosclerosis. This simulation indicates a relation between the deposited dose in the arteries following RAI treatment and an increased risk of atherosclerosis and subsequent cerebrovascular events such as stroke.
References
Stewart FA. Mechanisms and dose-response relationships for radiation-induced cardiovascular disease. Ann ICRP. 2012;41(3–4):72–9.
Directorate-General for Energy and Transport Directorate H—Nuclear Energy Unit H.4—Radiation Protection: EU Scientific Seminar 2008 “Emerging evidence for radiation induced circulatory diseases”. 2009; pp. 7–61 (Radiation protection NO 158).
Boerma M, Hauer-Jensen M. Preclinical research into basic mechanisms of radiation-induced heart disease. Cardiol Res Pract. 2011;. doi:10.4061/2011/858262.
United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). Annex A medical radiation exposures, apendix C, sources and effects of ionizing radiation: UNSCEAR 2008 report to the general assembly, with scientific annexes. New York: United Nations; 2010. pp. 139–69.
Stokkel MP, Handkiewicz JD, Lassmann M, Dietlein M, Luster M. EANM procedure guidelines for therapy of benign thyroid disease. Eur J Nucl Med Mol Imaging. 2010;37(11):2218–28.
Franklyn JA, Maisonneuve P, Sheppard MC, Betteridge J, Boyle P. Mortality after the treatment of hyperthyroidism with radioactive iodine. N Engl J Med. 1998;338(11):712–8.
Cooper DS, Biondi B. Subclinical thyroid disease. Lancet. 2012;379(9821):1142–54.
ICRP Publication 110. Adult reference computational phantoms. Annals ICRP. 2009;39(2):61–4.
Birchall A, Puncher M, Marsh JW, Davis K, Bailey MR, Jarvis NS, et al. IMBA professional plus: a flexible approach to internal dosimetry. Radiat Prot Dosim. 2007;125(1–4):194–7.
Sweezy J, Brown F, Booth T, Chiaramonte J, Preeg B. Automated variance reduction for MCNP using deterministic methods. Radiat Prot Dosim. 2005;116(1–4 Pt 2):508–12.
Mitchel RE, Hasu M, Bugden M, Wyatt H, Little MP, Gola A, et al. Low-dose radiation exposure and atherosclerosis in ApoE(−)/(−) mice. Radiat Res. 2011;175(5):665–76.
Conflict of interest
No potential conflicts of interest were disclosed.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
la Cour, J.L., Hedemann-Jensen, P., Søgaard-Hansen, J. et al. Modeling the absorbed dose to the common carotid arteries following radioiodine treatment of benign thyroid disease. Ann Nucl Med 27, 862–866 (2013). https://doi.org/10.1007/s12149-013-0756-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12149-013-0756-y